Profiel
Kamalam Unninayar served as the Chief Financial Officer at Harvard Bioscience, Inc. from 2018 to 2019 and at Tetraphase Pharmaceuticals, Inc. from 2017 to 2018.
She received a graduate degree from Wichita State University and both undergraduate and graduate degrees from the University of Delhi.
Eerdere bekende functies van Kamalam Unninayar
| Bedrijven | Functie | Einde |
|---|---|---|
| HARVARD BIOSCIENCE, INC. | Director of Finance/CFO | 31-05-2019 |
| TETRAPHASE PHARMACEUTICALS, INC. | Director of Finance/CFO | 16-03-2018 |
Opleiding van Kamalam Unninayar
| Wichita State University | Graduate Degree |
| University of Delhi | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| HARVARD BIOSCIENCE, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetraphase Pharmaceuticals, Inc. is engaged in the development and production of novel tetracyclines for serious and life-threatening bacterial infections. It also develops eravacycline, a synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Waltham, MA. | Health Technology |
